Please try another search
Anteris Technologies Ltd, a structural heart company, designs, develops, and commercializes medical devices. The company manufactures and sells ADAPT, a regenerative tissue product. Its lead product is the DurAVRTM, a transcatheter heart valve for the treatment of aortic stenosis. The company was formerly known as Admedus Limited and changed its name to Anteris Technologies Ltd in May 2020. Anteris Technologies Ltd was incorporated in 1999 and is based in Toowong, Australia.
Name | Age | Since | Title |
---|---|---|---|
John D. Seaberg | 70 | 2014 | Independent Chairman of the Board |
Wayne G. Paterson | 55 | 2014 | CEO, MD & Executive Director |
Wenyi Gu | - | 2018 | Non-Executive Director |
Bernard Prendergast | - | 2020 | TAVR Medical Advisory Board |
Vinnie Bapat | - | - | Member of Medical Advisory Board |
Karl Poon | - | 2022 | Member of Medical Advisory Board |
Paul Sorajja | - | - | Member of Medical Advisory Board |
Dion Stub | - | 2022 | Member of Medical Advisory Board |
Martin B. Leon | - | 2022 | Member of Global Medical Advisory Board |
Stephen Denaro | - | 2018 | Independent Non-Executive Director & Company Secretary |
Chris Meduri | - | 2021 | Chief Medical Officer & Member of Medical Advisory Board |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review